Skip to content

MELINTA THERAPEUTICS, INC. /NEW/: 10-Q filed 2013-04-25

What MELINTA THERAPEUTICS, INC. /NEW/ reported in its quarterly report filed 2013-04-25 (fiscal Q1 2013): 31 published measures, 91 facts as tagged in accession 0001193125-13-174054.

This filing

Form
10-Q (quarterly report)
Filed
2013-04-25
Fiscal period
fiscal Q1 2013
Accession
0001193125-13-174054 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All MELINTA THERAPEUTICS, INC. /NEW/ filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-03-3161,173,376USD
At 2012-12-3170,738,346USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-03-3112,757,350USD
At 2012-12-3112,967,994USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-03-3148,416,026USD
At 2012-12-3157,770,352USD
At 2011-12-31-96,685,150USD
At 2010-12-31-72,215,027USD
At 2009-12-31-49,445,819USD
At 2008-12-31-28,591,981USD
At 2007-12-31-11,258,128USD
At 2006-12-31-2,365,750USD
At 2005-12-31-26,463USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-03-3160,151,961USD
At 2012-12-3170,108,754USD
At 2012-03-3165,910,644USD
At 2011-12-3115,602,264USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-01-01 to 2013-03-31-9,937,990USD90
2005-11-17 to 2013-03-31-108,896,420USD2692
2012-01-01 to 2012-03-31-3,761,801USD91

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-01-01 to 2013-03-3118,803USD90
2005-11-17 to 2013-03-31303,862USD2692
2012-01-01 to 2012-03-314,903USD91

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2005-11-17 to 2013-03-31169,352,243USD2692
2012-01-01 to 2012-03-3154,075,084USD91

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-01-01 to 2013-03-31-18,803USD90
2005-11-17 to 2013-03-31-303,862USD2692
2012-01-01 to 2012-03-31-4,903USD91

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2013-01-01 to 2013-03-310USD90

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-03-3156,091USD
At 2012-12-3143,217USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-01-01 to 2013-03-31990,584USD90
2005-11-17 to 2013-03-313,683,154USD2692
2012-01-01 to 2012-03-31164,487USD91

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-03-31-10,018,213USD90
2005-11-17 to 2013-03-31-115,308,233USD2692
2012-01-01 to 2012-03-31-2,848,319USD91

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-03-3160,795,891USD
At 2012-12-3170,373,735USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-01-01 to 2013-03-31327,286USD90
2005-11-17 to 2013-03-315,966,608USD2692
2012-01-01 to 2012-03-31406,598USD91

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-03-315,827,568USD
At 2012-12-315,344,709USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2013-03-311,608,057USD
At 2012-12-312,171,633USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2005-11-17 to 2013-03-31475,699USD2692

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-01-01 to 2013-03-3110,018,213USD90
2005-11-17 to 2013-03-31115,308,233USD2692
2012-01-01 to 2012-03-312,848,319USD91

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-01-01 to 2013-03-317,370,960USD90
2005-11-17 to 2013-03-3191,098,520USD2692
2012-01-01 to 2012-03-311,876,218USD91

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-03-3124,903,774shares
At 2012-12-3124,903,774shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-03-31179,961,559USD
At 2012-12-31178,970,975USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2013-03-31-131,570,437USD
At 2012-12-31-121,225,527USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2013-03-31275,644USD
At 2012-12-31282,084USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-03-31219,553USD
At 2012-12-31238,867USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2013-03-31998,874USD
At 2012-12-31341,918USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2013-01-01 to 2013-03-31-10,344,910USD90
2005-11-17 to 2013-03-31-119,312,184USD2692
2012-01-01 to 2012-12-31-24,226,789USD366
2012-01-01 to 2012-03-31-3,149,710USD91
2011-01-01 to 2011-12-31-21,220,779USD365
2010-01-01 to 2010-12-31-19,674,924USD365
2009-01-01 to 2009-12-31-18,611,814USD365
2008-01-01 to 2008-12-31-14,902,317USD366
2007-01-01 to 2007-12-31-8,075,240USD365
2006-01-01 to 2006-12-31-2,228,948USD365
2005-11-19 to 2005-12-31-26,463USD43

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2013-01-01 to 2013-03-31-10,344,910USD90
2005-11-17 to 2013-03-31-133,315,026USD2692
2012-01-01 to 2012-03-31-3,463,298USD91

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-01-01 to 2013-03-312,647,253USD90
2005-11-17 to 2013-03-3124,209,713USD2692
2012-01-01 to 2012-03-31972,101USD91

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2013-01-01 to 2013-03-315,929USD90
2005-11-17 to 2013-03-31247,772USD2692
2012-01-01 to 2012-03-3118,046USD91

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2013-01-01 to 2013-03-31-326,697USD90
2005-11-17 to 2013-03-31-4,003,951USD2692
2012-01-01 to 2012-03-31-301,391USD91

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2013-01-01 to 2013-03-31238,750USD90
2005-11-17 to 2013-03-311,159,264USD2692
2012-01-01 to 2012-03-31206,000USD91

Inspect the source

Entity
MELINTA THERAPEUTICS, INC. /NEW/ / CIK 0001461993
Captured
SEC response SHA-256
a91f8f211753f3d9ac6e05de33d49dcc2bb8e612652c27bc45fa4809eebdc607

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001461993.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))